Slide 1
A United Force Against Inflammatory Breast Cancer
The Susan G. Komen-IBCRF IBC Collaborative in partnership with the Milburn Foundation is committed to accelerating IBC research and improving care and outcomes for people with IBC.
Slide 2
Challenges of Diagnosing Inflammatory Breast Cancer (IBC)

IBC is a rare and aggressive breast cancer. It often resembles a breast infection, making it challenging to diagnose. Hear from clinicians and patient advocates about the warning signs and symptoms of IBC.

Slide 2
An Inflammatory Breast Cancer (IBC) Scoring System to Help Accelerate Diagnosis and Improve Outcomes

Learn about the IBC Scoring System, a proposed, first-of-its kind tool for IBC. This system is being developed to increase diagnostic accuracy, guide treatment decisions and inclusion in clinical trials and aid research.

Slide 2
Treating Inflammatory Breast Cancer (IBC)

IBC develops rapidly and requires aggressive care. Hear from experts about the importance of providing effective and coordinated care to people with IBC.

previous arrow
next arrow

IBC Expert Views and Insights

Hear from IBC researchers and patients who are helping to make an impact.

Expert Views:
Defining IBC Improves Diagnosis and Outcomes

Treating Inflammatory Breast Cancer (IBC)​

Challenges of Diagnosing Inflammatory Breast Cancer (IBC)​

‘I Found Out I Had Inflammatory Breast Cancer by Accident’

Know the Facts about IBC

Explore resources to help you understand the signs, symptoms and treatments for IBC.

Collaborating to Advance IBC Research

Susan G. Komen along with the Inflammatory Breast Cancer Research Foundation (IBCRF) and the Milburn Foundation have partnered to accelerate IBC research and improve care and outcomes for people with IBC.

The History of the Inflammatory Breast Cancer Collaborative

1-877 GO KOMEN

Need Help?

Our Breast Care Helpline offers free support and information about breast health, breast cancer, local and national resources and clinical trials from trained oncology social workers and specialists. 

Monday – Thursday, 9 a.m. – 7 p.m. ET and Friday, 9 a.m. – 6 p.m. ET
Se habla español.